The significance of highlighting the oestrogen receptor low category in breast cancer

por Poon, Ivan K., Tsang, Julia Y., Li, Joshua, Chan, Siu-Ki, Shea, Ka-Ho, Tse, Gary M.
Publicado 2020

FGFR1 is an adverse outcome indicator for luminal A breast cancers

por Shi, Yu-Jie, Tsang, Julia Y.S., Ni, Yun-Bi, Chan, Siu-Ki, Chan, Kui-Fat, Tse, Gary M.
Publicado 2015

Doublecortin-like kinase 1 expression associates with breast cancer with neuroendocrine differentiation

por Liu, Yu-Hong, Tsang, Julia Y.S., Ni, Yun-Bi, Hlaing, Thazin, Chan, Siu-Ki, Chan, Kui-Fat, Ko, Chun-Wai, Mujtaba, S. Shafaq, Tse, Gary M.
Publicado 2015

The Clinical Value of PELP1 for Breast Cancer: A Comparison with Multiple Cancers and Analysis in Breast Cancer Subtypes

por Wang, Xingen, Tsang, Julia Y. S., Lee, Michelle A, Ni, Yun-Bi, Tong, Joanna H, Chan, Siu-Ki, Cheung, Sai-Yin, To, Ka Fai, Tse, Gary M
Publicado 2019

Human placenta as an ex vivo vascular model for neurointerventional research

por Kwok, John Ching Kwong, Huang, Wei, Leung, Wing-Cheong, Chan, Siu-Ki, Chan, Kwong-Yau, Leung, Kar-Ming, Chu, Alberto Chi Ho, Lam, Alexander Kar Ngai
Publicado 2014

Proteolytic cleavage of amyloid precursor protein by ADAM10 mediates proliferation and migration in breast cancer

por Tsang, Julia Y.S., Lee, Michelle A., Chan, Tsz-Hei, Li, Joshua, Ni, Yun-Bi, Shao, Yan, Chan, Siu-Ki, Cheungc, Sai-Yin, Lau, Kwok-Fai, Tse, Gary M.K.
Publicado 2018